S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
OTCMKTS:MSLP

MusclePharm Stock Forecast, Price & News

$0.64
+0.03 (+4.92 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.60
$0.64
50-Day Range
$0.65
$1.65
52-Week Range
$0.06
$3.00
Volume
3,695 shs
Average Volume
18,739 shs
Market Capitalization
$21.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.43
30 days | 90 days | 365 days | Advanced Chart
Receive MSLP News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.


MusclePharm logo

About MusclePharm

MusclePharm Corp. engages in the development, manufacture, and distribution of branded sports nutrition products and nutritional supplements. It offers a broad range of performance powders, capsules, tablets, and gels that satisfy the needs of enthusiasts and professionals alike. It focuses on MusclePharm and FitMiss brands. The company was founded by Bradley J. Pyatt and Cory J. Gregory on August 4, 2006 and is headquartered in Calabasas, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MSLP
Employees
27
Year Founded
N/A

Sales & Book Value

Annual Sales
$64.44 million
Cash Flow
$0.11 per share
Book Value
($0.72) per share

Profitability

Net Income
$3.18 million
Pretax Margin
2.17%

Debt

Price-To-Earnings

Miscellaneous

Free Float
13,499,000
Market Cap
$21.98 million
Next Earnings Date
11/22/2021 (Estimated)
Fiscal Year End
December 31
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












MusclePharm (OTCMKTS:MSLP) Frequently Asked Questions

What stocks does MarketBeat like better than MusclePharm?

Wall Street analysts have given MusclePharm a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MusclePharm wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MusclePharm?

MusclePharm saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 800 shares, a decline of 42.9% from the September 30th total of 1,400 shares. Based on an average trading volume of 22,400 shares, the short-interest ratio is presently 0.0 days.
View MusclePharm's Short Interest
.

When is MusclePharm's next earnings date?

MusclePharm is scheduled to release its next quarterly earnings announcement on Monday, November 22nd 2021.
View our earnings forecast for MusclePharm
.

How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) issued its quarterly earnings data on Monday, August, 16th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $14.91 million for the quarter. MusclePharm had a net margin of 2.26% and a negative trailing twelve-month return on equity of 5.24%.
View MusclePharm's earnings history
.

How has MusclePharm's stock been impacted by COVID-19?

MusclePharm's stock was trading at $0.18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MSLP shares have increased by 255.6% and is now trading at $0.64.
View which stocks have been most impacted by COVID-19
.

Who are MusclePharm's key executives?

MusclePharm's management team includes the following people:
  • Ryan Charles Drexler, Executive Chairman & Chief Executive Officer
  • Sabina Rizvi, President & Chief Financial Officer

What other stocks do shareholders of MusclePharm own?

What is MusclePharm's stock symbol?

MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."

How do I buy shares of MusclePharm?

Shares of MSLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MusclePharm's stock price today?

One share of MSLP stock can currently be purchased for approximately $0.64.

How much money does MusclePharm make?

MusclePharm has a market capitalization of $21.98 million and generates $64.44 million in revenue each year.

How many employees does MusclePharm have?

MusclePharm employs 27 workers across the globe.

What is MusclePharm's official website?

The official website for MusclePharm is www.musclepharm.com.

Where are MusclePharm's headquarters?

MusclePharm is headquartered at 4400 VANOWEN STREET, BURBANK CA, 80239.

How can I contact MusclePharm?

MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 80239. The company can be reached via phone at (800) 292-3909 or via email at [email protected].


This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.